Silencing Protein Kinase C Ζ by Microrna-25-5p Activates AMPK Signaling and Inhibits Colorectal Cancer Cell Proliferation.

Shihu Zhang,Yiyang Zhang,Qing Cheng,Zhaoqun Ma,Guanwen Gong,Zhengming Deng,Kun Xu,Gaoyuan Wang,Yousong Wei,Xiaoping Zou

DOI: https://doi.org/10.18632/oncotarget.18649

2017-01-01

Oncotarget

Abstract:Developing novel strategies against human colorectal cancer (CRC) cells is needed. Activation of AMP-activated protein kinase (AMPK) could possibly inhibit CRC cells. Protein kinase C zeta (PKC zeta) is an AMPK negative regulator. Here we found that PKC zeta expression was significantly elevated in human colon cancer tissues and CRC cells. PKC zeta upregulation was correlated with AMPK in-activation and mTOR complex 1 (mTORC1) over-activation. Reversely, PKC zeta shRNA knockdown activated AMPK signaling and inhibited HT-29 cell proliferation. Significantly, downregulation of microRNA-25-5p (miR-25-5p), a PKC zeta-targeting miRNA, could be the cause of PKC zeta upregulation. Exogenous expression of miR-25-5p silenced PKC zeta to activate AMPK signaling, which inhibited HT-29 cell proliferation. In vivo studies showed that HT-29 xenograft growth in mice was inhibited after expressing PKC zeta shRNA or miR-25-5p. Collectively, PKC zeta could be a novel oncogenic protein of human CRC. PKC zeta silence, by targeted-shRNA or miR-25-5p expression, activates AMPK and inhibits HT-29 cell proliferation.